Goodin BR

No ORCID on file · 1 paper in corpus
2015
Current pharmaceutical design ·doi:10.2174/1381612820666141027111843

The treatment of chronic pain arising from deep tissues is currently inadequate and there is need for new pharmacological agents to provide analgesia. The endogenous paracrine hormone/neurotransmitter oxytocin is intimately involved in the …